OREXIGEN THERAPEUTICS INC - COM NEW (OREXQ)

CUSIP: 686164302

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM NEW
Total 13F shares
822,035
Share change
+822,035
Total reported value
$354,000
Price per share
$0.43
Number of holders
5
Value change
+$354,000
Number of buys
5

Quarterly Holders Quick Answers

What is CUSIP 686164302?
CUSIP 686164302 identifies OREXQ - OREXIGEN THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OREXIGEN THERAPEUTICS INC - COM NEW (OREXQ) as of Q2 2016

As of 30 Jun 2016, OREXIGEN THERAPEUTICS INC - COM NEW (OREXQ) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 822,035 shares. The largest 5 holders included DOWLING & YAHNKE LLC, STATE STREET CORP, PANAGORA ASSET MANAGEMENT INC, HOWARD CAPITAL MANAGEMENT, and TUDOR INVESTMENT CORP ET AL. This page lists 5 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.